Clinical pharmacology of thalidomide (original) (raw)
Related papers
Pharmacological Properties of Thalidomide and its Analogues
Reinaldo Compagnone, Michael Mijares, Juan Sanctis
Recent Patents on Inflammation & Allergy Drug Discovery, 2010
Thalidomide: An experience in therapeutic outcome and adverse reactions
Journal of Dermatological Treatment, 2007
Clinical Cancer Research, 2004
Recent advances in analytical determination of thalidomide and its metabolites
Journal of Pharmaceutical and Biomedical Analysis, 2008
Thalidomide in Oncology: The Peril and the Promise
Cancer control : journal of the Moffitt Cancer Center, 1999
Thalidomide and Its Analogs as Anticancer Agents
Mechanisms of action and potential therapeutic uses of thalidomide
Croatian medical journal, 2002
Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug
Current Medicinal Chemistry, 2013
Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Current Drug Therapy, 2012
Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
Journal of the American Academy of Dermatology, 1996
Thalidomide: from tragedy to promise
Swiss Medical Weekly, 2003
Clinical Trials of Drug – Thalidomide, and Its Derivatives
chemistry and materials research, 2017
Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide
Current Drug Metabolism, 2006
European Journal of Pharmaceutical Sciences, 2004
Eur J Pharm Sci 21 465 469, 2004
Anna Cancela, Luciane Di Leone, Sabrina Alves Fernandes
Investigational New Drugs, 2003
Adverse effects of thalidomide administration in patients with neoplastic diseases
The American Journal of Medicine, 2004
High Anti-Inflammatory Activity and Low Toxicity of Thalidomide Analogs
Medicinal Chemistry, 2015
Chemical and Pharmaceutical Bulletin, 2006
Thalidomide Therapy:An Open Trial
International Journal of Dermatology, 2007
Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery, 2007
Physicochemical Characterization and Solubility Analysis of Thalidomide and Its N-Alkyl Analogs
Jeanetta Du Plessis, Dr. ritesh bathe
Pharmaceutical Research, 2002
Journal of Chromatography B, 2012
Thalidomide for treatment of multiple myeloma: 10 years later
Blood, 2008
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development
Therapeutic advances in hematology, 2011
Thalidomide analogs and PDE4 inhibition
Bioorganic & Medicinal Chemistry Letters, 1998
Enantioselective inhibition of TNF? release by thalidomide and thalidomide-analogues
Chirality, 1996
Pharmacokinetics of thalidomide in an elderly prostate cancer population
Journal of Pharmaceutical Sciences, 1999
Immunomodulation by thalidomide and thalidomide analogues
Annals of the rheumatic diseases, 1999
Neuroprotective effect of thalidomide on MPTP-induced toxicity
NeuroToxicology, 2015
Journal of Pharmacy and Pharmacology, 2003